Last updated: 22 July 2019 at 10:14pm EST

Kathleen M O Donnell Net Worth




The estimated Net Worth of Kathleen M O Donnell is at least $936 Thousand dollars as of 25 October 2004. Kathleen Donnell owns over 2,500 units of Biodelivery Sciences International stock worth over $935,766 and over the last 20 years Kathleen sold BDSI stock worth over $0.

Kathleen Donnell BDSI stock SEC Form 4 insiders trading

Kathleen has made over 16 trades of the Biodelivery Sciences International stock since 2004, according to the Form 4 filled with the SEC. Most recently Kathleen bought 2,500 units of BDSI stock worth $8,875 on 25 October 2004.

The largest trade Kathleen's ever made was buying 25,000 units of Biodelivery Sciences International stock on 27 August 2004 worth over $71,750. On average, Kathleen trades about 8,082 units every 4 days since 2004. As of 25 October 2004 Kathleen still owns at least 167,400 units of Biodelivery Sciences International stock.

You can see the complete history of Kathleen Donnell stock trades at the bottom of the page.



What's Kathleen Donnell's mailing address?

Kathleen's mailing address filed with the SEC is C/O MCCABE & O'DONNELL, 3101 NORTH CENTRAL AVENUE, SUITE 700, PHOENIX, AZ, 85012.

Insiders trading at Biodelivery Sciences International

Over the last 21 years, insiders at Biodelivery Sciences International have traded over $111,671,776 worth of Biodelivery Sciences International stock and bought 1,813,177 units worth $5,352,510 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott, and Healthcare Master Fund Ltd .... On average, Biodelivery Sciences International executives and independent directors trade stock every 18 days with the average trade being worth of $420,648. The most recent stock trade was executed by Jeffrey Allen Bailey on 9 March 2022, trading 5,333 units of BDSI stock currently worth $29,811.



What does Biodelivery Sciences International do?

BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.



Complete history of Kathleen Donnell stock trades at Biodelivery Sciences International

Insider
Trans.
Transaction
 Total value
Kathleen M O Donnell
10% owner
 Buy $8,875
25 Oct 2004
Kathleen M O Donnell
10% owner
 Buy $26,625
18 Oct 2004
Kathleen M O Donnell
10% owner
 Buy $20,450
12 Oct 2004
Kathleen M O Donnell
10% owner
 Buy $34,100
6 Oct 2004
Kathleen M O Donnell
10% owner
 Buy $14,000
4 Oct 2004
Kathleen M O Donnell
10% owner
 Buy $14,700
30 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $7,350
24 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $7,225
22 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $28,809
20 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $20,850
15 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $7,375
13 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $109,275
9 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $29,800
3 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $43,350
1 Sep 2004
Kathleen M O Donnell
10% owner
 Buy $71,750
27 Aug 2004
Kathleen M O Donnell
10% owner
 Buy $56,000
26 Aug 2004


Biodelivery Sciences International executives and stock owners

Biodelivery Sciences International executives and other stock owners filed with the SEC include: